Here, we report that high miR-205-5p expression is associated with low recurrence-free survival in HNSCC patients and that its upregulation is significantly related to the subgroup of tumors with TP53 mutated (Figure 6). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.